Oxford Nanopore Technologies, founded in 2005, develops and commercializes nanopore-based DNA/RNA sequencing technology. The company's platform enables real-time, scalable analysis of biological molecules, serving scientific research, healthcare, and industrial applications across more than 120 countries.
Its product portfolio includes the MinION, a portable sequencing device, and the PromethION, a high-throughput benchtop system. The technology is built on expertise spanning nanopore science, molecular biology, informatics, engineering, and manufacturing.
With a team of over 1,000 people, the company operates at a global scale, supporting a wide range of sequencing applications from field-based research to large-scale genomic studies.
